Susquehanna International Group, LLP Cel Sci Corp Transaction History
Susquehanna International Group, LLP
- $560 Billion
- Q3 2024
A detailed history of Susquehanna International Group, LLP transactions in Cel Sci Corp stock. As of the latest transaction made, Susquehanna International Group, LLP holds 80,345 shares of CVM stock, worth $49,813. This represents 0.0% of its overall portfolio holdings.
Number of Shares
80,345
Previous 97,902
17.93%
Holding current value
$49,813
Previous $113,000
24.78%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding CVM
# of Institutions
71Shares Held
6MCall Options Held
27.1KPut Options Held
150K-
Vanguard Group Inc Valley Forge, PA2.41MShares$1.49 Million0.0% of portfolio
-
Black Rock Inc. New York, NY775KShares$480,3160.0% of portfolio
-
Geode Capital Management, LLC Boston, MA613KShares$379,9730.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ432KShares$267,9180.0% of portfolio
-
State Street Corp Boston, MA194KShares$119,9740.0% of portfolio
About CEL SCI CORP
- Ticker CVM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,367,500
- Market Cap $26.9M
- Description
- CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...